Reply to the letter to the editor 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting' by van der Galien € et al

M. J. Maurer, T. M. Habermann

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)153
Number of pages1
JournalAnnals of Oncology
Volume30
Issue number1
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this